stockrowTeleflex Incorporated
TFX Healthcare Medical Instruments & Supplies
Teleflex Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $2.0 billion, up 17.2% from fiscal 2024.
- Revenue
- +28.9%
- EPS
- −17.3%
- Free cash flow
- +220.1%
- Total debt
- +47.7%
Quarter to June 2026, against a year earlier
Follow TFX
Alert me
Teleflex Incorporated (TFX) Net income
Teleflex Incorporated's net income for fiscal 2025 was −$905.6M, compared with $69.7M in fiscal 2024. Over the twelve months to 30 June 2026 it was −$1.0B. Over the past ten years it has ranged from −$905.6M (fiscal 2025) to $485.4M (fiscal 2021) — the current reading is the lowest in ten years. Net income has fallen for 4 consecutive fiscal years. Teleflex Incorporated ranks 51st of 51 Medical Instruments & Supplies companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2025 | −$905.6M | — |
| FY2024 | $69.7M | (80.45%) |
| FY2023 | $356.3M | (1.88%) |
| FY2022 | $363.1M | (25.18%) |
| FY2021 | $485.4M | 44.75% |
| FY2020 | $335.3M | (27.34%) |
| FY2019 | $461.5M | 129.81% |
| FY2018 | $200.8M | 31.65% |
| FY2017 | $152.5M | (35.87%) |
| FY2016 | $237.8M | (3.20%) |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Jun 2026 | $99.7M | — |
| Mar 2026 | −$8.2M | — |
| Dec 2025 | −$714.3M | — |
| Sep 2025 | −$408.9M | — |
| 42 more quarters | Free account |
Against its own ten years
Net income against peers
| Company | Net income |
|---|---|
| NVST Envista Holdings Corporation compare | $633.6M |
| AVTR Avantor, Inc. compare | $337.2M |
| ATR AptarGroup, Inc. compare | $267.9M |
| MMSI Merit Medical Systems, Inc. compare | $160.1M |
| ICUI ICU Medical, Inc. compare | $60.3M |
| PLSE Pulse Biosciences, Inc compare | −$83.8M |
| BLCO Bausch + Lomb Corporation compare | −$103.0M |
| MMED MiniMed Group, Inc. compare | −$320.0M |
| TFX Teleflex Incorporated | −$1.0B |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on TFX
- Revenue
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement